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The aim of the current study was to evaluate primary (human bronchial epithelial cells, HBEC) and non-primary (Calu-3, BEAS-
2B, BEAS-2B R1) bronchial epithelial cell culture systems as air-liquid interface- (ALI-) diﬀerentiated models for asthma research.
Ability to diﬀerentiate into goblet (MUC5AC+) and ciliated (β-Tubulin IV+) cells was evaluated by confocal imaging and qPCR.
Expressionoftightjunction/adhesionproteins(ZO-1,E-Cadherin)anddevelopmentoftransepithelialelectricalresistance(TEER)
were assessed. Primary cells showed localised MUC5AC, β-Tubulin IV, ZO-1, and E-Cadherin and developed TEER with, however,
a large degree of inter- and intradonor variation. Calu-3 cells developed a more reproducible TEER and a phenotype similar to
primary cells although with diﬀuse β-Tubulin IV staining. BEAS-2B cells did not diﬀerentiate or develop tight junctions. These
datahighlightthechallengesinworkingwithprimarycellmodelsandtheneedforcarefulcharacterisationandselectionofsystems
to answer speciﬁc research questions.
1.Introduction
Asthma is a chronic respiratory condition characterised by
recurrent exacerbations [1]. A feature of asthma (especially
severe asthma) is airway remodelling, that is, increased
smooth muscle mass, ﬁbrosis, and excessive mucus produc-
tion [2]. The epithelium plays a key role in the development
of airway remodelling and inﬂammation as it represents
the primary barrier to environmental exposures and also
signals to other cell types within the context of the epithelial
mesenchymal trophic unit [3, 4].
In vitro models using primary cells and cell lines are
essential for understanding the function of the epithelium
relevanttoasthma.Cellsareroutinelyculturedinsubmerged
monolayers on a plastic substrate. In order to obtain a more
physiological model, primary human bronchial epithelial
cells (HBECs) may be cultured at air-liquid interface (ALI)
using deﬁned medium to drive a diﬀerentiated phenotype
[5]. This model shows a pseudostratiﬁed, polarised pheno-
type, including ciliated and goblet cells and develops high
transepithelial electrical resistance (TEER) [6, 7]. Measure-
ment of TEER provides an indirect measure of formation of
tight junctions and is often used as a marker of disruption of
the epithelial layer [8].
Cultured primary HBECs from asthma and non-asthma
subjects have been compared in a number of studies, to
investigate intrinsic diﬀerences in the asthmatic epithelium.
Epithelial cells from asthmatic patients display diﬀerential
expressionofgenesassociatedwithinﬂammation,repair,and
remodelling and have been shown to diﬀer from normal
cells in culture, including increased proliferation [9]a n d
slower repair of a mechanical wound [10, 11]. Several groups
have cultured asthmatic epithelial cells at ALI, showing a less
diﬀerentiated phenotype, that is, increased numbers of basal
cells [12] or decreased tight junction formation [13], and
diﬀering responses to stimulation including viral infection,
mechanical wounding, and cigarette smoke [12–14]. There
hasbeensomedebateregardingreporteddiﬀerencesbetween
normal and asthmatic cells. For instance, Hackett et al. [12]
report no diﬀerence in TEER between normal and asthmatic2 Journal of Allergy
cultures, whilst Xiao and colleagues suggest that cells from
asthmatic subjects show decreased TEER and disrupted tight
junctions [13]. These discrepancies may reﬂect diﬀerences
in donor proﬁle (donors were signiﬁcantly older in the Xiao
study), cell source (post mortem donor lungs versus bronchial
brushings), or the much greater number of subjects included
in the Xiao study. Paediatric asthmatic HBECs in monolayer
culture show slower repair of a mechanical wound [10, 11].
AtALI,HBECsfromasthmadonorsshowincreasedcytokine
release in response to mechanical wounding, or viral or
particulate matter exposure [12], and are more sensitive
to disruption of TEER by cigarette smoke extract [13].
AnotherstudyfoundthatwhilstHBECsfromnormaldonors
showed an increased rate of wound repair in response to
IL-1β treatment, asthmatic cells did not show this response
[14]. These results may suggest that asthmatic cells at ALI
have an intrinsically diﬀerent phenotype and show diﬀerent
signalling responses to normal cells and support the utility of
epithelial cell culture in asthma research.
Direct comparisons of normal and asthmatic cells allow
characterisation of the asthmatic phenotype; however, they
are less helpful when trying to dissect the underlying
mechanisms behind epithelial changes in asthma. Normal
primary bronchial epithelial cells and cell lines may be used
to model various aspects of asthma. Cytokines may be added
to cells in monolayer or ALI culture [15–17], whilst asthma
triggers such as Derp1 or rhinovirus have been applied to
the cells to mimic allergen inhalation or viral exacerbation
[18, 19]. Danahay et al. treated ALI HBECs with IL-13 or IL-
4, resulting in changes in permeability, suggesting that these
asthma-related cytokines may contribute to a more secretory
phenotype[15],whilstWadsworthandcolleaguesfoundthat
addition of IL-13 and other TH2 cytokines led to increased
MMP7andFasLrelease,whichmayleadtoepithelialdamage
and inﬂammation [16]. In another study, HBEC or BEAS-
2B cells at ALI were treated with leukotriene D4, resulting in
signalling via EGFR and release of IL-8 [17]. Overall these
data demonstrate that the use of HBEC and cell line cultures
can provide a unique insight into mechanisms underlying
asthma and it is important to understand the strengths and
weaknesses of these culture systems.
Accumulating data suggest that bronchial epithelial cells
may be a viable drug target in asthma [20]. Cell culture
models are used in drug development, both to assess the
direct eﬀect of potential drugs on cell function and sig-
nalling and to investigate drug uptake and metabolism [21].
Although primary cells are the gold standard, there are some
disadvantages to their use including cost, limited life span,
and variability between donors, passage, or experiments.
Primary cells may also be more diﬃcult to transfect or
otherwise manipulate. This has led to the use of cell line
systems, in both monolayer culture and at ALI. The Calu-
3 cell line was established from a pleural eﬀusion of a lung
adenocarcinoma,derivedfromsubmucosalglandserouscells
[22–24].ItisoftenusedatALIasamodelsystem,particularly
for investigations of tight junction and barrier formation
[23], for instance, showing that rhinovirus infection leads
to decreased TEER and increased permeability [19]. The
BEAS-2B cell line, originally developed by immortalization
ofnormalhumanbronchialepithelialcellsusingAD12-SV40
virus [25], has been less frequently used at ALI; however
there is some literature using BEAS-2B in this system [17,
26]. Although these cells have been separately characterised
by techniques such as immunoﬂuorescence and TEER, no
systematic comparison of primary cell and cell line culture
models in this system has been reported.
The aim of the current study was to evaluate primary
and non-primary bronchial epithelial cell culture systems
as (ALI-) diﬀerentiated models for asthma research. We
cultured primary HBECs from two donors, Calu-3, BEAS-
2 B ,a n dB E A S - 2 BR 1( as u b c l o n eo fB E A S - 2 B ,c u l t u r e di n
the presence of foetal calf serum (FCS)) in their respective
media at ALI. Development of TEER was measured over
28 days, RNA was collected at days 7, 14, and 21, and
immunoﬂuorescence was performed at day 28. We measured
expression of a panel of diﬀerentiation (β-Tubulin IV, a
ciliated cell marker, and MUC5AC, a goblet cell marker
[27]) and tight junction/adhesion (E-Cadherin and ZO-1)
markers by real-time quantitative PCR (qPCR) and confocal
imagingtoallowdirectcomparisonofthephenotypeofthese
diﬀerent cell systems.
We show that although primary cells develop a diﬀeren-
tiated phenotype, their TEER is highly variable, conﬁrming
the need to use multiple experiments and donors in primary
cell systems. Calu-3 cells showed high TEER and similar
expression of markers compared to primary cells, suggesting
that these cells may be the most suitable model cell line
for ALI experiments. Our work (1) indicates that all model
systems, including primary cells, should be validated to
ensure that the most suitable model is being used for a
speciﬁc research question and (2) highlights the diﬃculties
in utilising primary cells in epithelial cell research.
2.MaterialsandMethods
2.1. Cell Culture and ALI Diﬀerentiation. Human bronchial
epithelial cells (NHBEC, Lonza, Wokingham, UK) were ex-
panded in growth factor-supplemented medium (BEGM,
Lonza) and diﬀerentiated at (ALI) at passage 3-4 in diﬀeren-
tiationmedium(BEDM)accordingtoapreviouslypublished
method [15, 28]. BEDM was composed of 50:50 Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM, Sigma):BEBM (Lonza)
with Lonza singlequots, excluding triiodo-L-thyronine and
retinoic acid, but including GA-1000 (Gentamicin and
Amphotericin-B). BEDM was supplemented with 50nM
retinoic acid at time of use. All experiments were performed
using a single lot of BEBM and singlequots to avoid batch
variation. Medium was used within one month of prepara-
tion, as recommended by Lonza.
Calu-3 lung adenocarcinoma cells [22] (obtained from
ATCC) were cultured in Dulbecco’s Modiﬁed Eagle’s Medi-
um/Nutrient Mixture F-12 Ham (DMEM/F12) (Sigma)
supplementedwith10%FCS,1%MEMnon-essentialamino
acid solution (Sigma), and 1% Penicillin/Streptomycin
(Sigma). BEAS-2B [25], a transformed bronchial epithelial
cellline(giftfromDrR.Clothier,UniversityofNottingham),
was cultured in BEGM and diﬀerentiated at ALI in BEDM.Journal of Allergy 3
Table 1: Antibodies used for immunoﬂuorescent staining of cultured cells.
Target Antibody Dilution Secondary
β-Tubulin IV Sigma T7941 1:500
Goat anti-Mouse FITC
(Sigma F0257) 1:100
MUC5AC Abcam AB3649 1:250
E-Cadherin Millipore MAB3199Z 1:500
Mouse IgG Isotype Sigma M7894 1:463
ZO-1 Invitrogen 40-2200 1:125 Goat anti-Rabbit Rhodamine TRITC
(Stratech 111-025-003) 1:100 Rabbit IgG Isotype Abcam AB27472 1:1
Table 2: Primers and TaqMan probes used for qPCR assays.
Target Primers Probe
β-Tubulin IV AGATCGTGCACCTGCAGG CCAGTGCGGCAACCAGATCGG
CATGGTATGTGCCTGTGG
MUC5AC TACTCCACAGACTGCACCAACTG TGTGCTTGGAGGTGCCCACTTCTCAA
CGTGTATTGCTTCCCGTCAA
E-Cadherin CCCACCACGTACAAGGGTC CGAGGCTAACGTCGTAATCACCACACTGA
CTGGGGTATTGGGGGCATC
ZO-1 GCGGTCAGAGCCTTCTGATC ACTCGCCGCAGCAGCCAAGCAAT
CATGCTTTACAGGAGTTGAGACAG
BEAS-2B R1 [29]( as u b c l o n eo fB E A S - 2 B )( g i f tf r o mD r .
R. Penn, University of Maryland, Philadelphia, PA) was
cultured in DMEM supplemented with 10% FCS and 1%
Penicillin/Streptomycin. All cells were cultured on 12mm
polyester Transwell inserts with a pore size of 0.4μm
(Corning NY, USA). Cells were plated at 100,000cells per
insert in appropriate medium. When conﬂuent (∼3 days),
cells were raised to ALI. Medium was replaced and the apical
face washed with phosphate-buﬀered saline (PBS) every 48
hours. RNA was extracted after 7, 14, and 21 days at ALI and
cells were ﬁxed for immunostaining after 28 days at ALI.
2.2. Transepithelial Electrical Resistance (TEER). The trans-
epithelial electrical resistance (TEER) was measured in
diﬀerentiating cells using an EVOM2 epithelial volt-ohm
meter (World precision Instruments UK, Stevenage), over 21
to 28 days at ALI to conﬁrm development of tight junctions.
Brieﬂy, medium was aspirated and replaced with 1mL in the
basolateral and 0.5mL in the apical compartment. Cultures
were equilibrated in the incubator for 30 minutes before
measurement of TEER. Apical medium was then aspirated
to restore ALI. TEER of insert and medium alone was
subtracted from measured TEER and Ω·cm2 calculated by
multiplying by the insert area.
2.3. Immunoﬂuorescence of Cultured Cells. ALI cultured cells
were ﬁxed in situ on inserts and transferred to glass slides
for visualisation. Cells were ﬁxed using 4% formaldehyde
and blocked/permeabilised with PBS, 10% goat serum,
1% BSA, and 0.15% Triton-X. Cells were incubated with
appropriate primary antibodies at 4◦C overnight (Table 1),
and FITC or rhodamine-TRITC labelled secondary for 1
hour at room temperature before mounting in HardSet
DAPI(VectorLabs).Controlswereincubatedwithsecondary
antibody alone or primary isotype control antibody followed
by secondary antibody. Cells were visualized using the Zeiss
spinning disk confocal microscope using Volocity software
(version 5.5, PerkinElmer, Cambridge, UK).
2.4. Quantitative PCR (qPCR). Cultured cells were lysed
and RNA was extracted using silica columns (RNeasy mini
kit, Qiagen, Crawley, UK). cDNA was synthesized using
SuperscriptII(Invitrogen,Paisley,UK)andrandomhexamer
primers as per instructions. mRNA levels were quantiﬁed
using a series of TaqMan assays (Table 2). Probes were
labelled with FAM and TAMRA. qPCR was performed
using TaqMan gene expression master mix (Applied Biosys-
tems, Warrington, UK) and HPRT1 (4310890E, Applied
Biosystems) endogenous control on a Stratagene MxPro3005
machine using 40 cycles of 95◦C1 5 s e c ,6 0 ◦C6 0 s e c .D a t a
were normalised using the housekeeper (HPRT1) and the
2−ΔCt method.
3. Results
3.1. Primary Epithelial Cells and Cell Lines Develop TEER
When Cultured at ALI. Primary HBECs (2 donors) and cell
lineswereculturedatALIandTEERmeasuredevery2-3days
for 21–28 days (Figure 1, Table 3). All primary cell experi-
ments were performed at passage 3-4 from diﬀerent frozen
vials. Experiments performed at passage three (two in Donor
1, one in Donor 2) developed TEER >350Ω·cm2, whilst
experiments performed at passage four developed TEER
<150Ω·cm2 (Figures 1(a) and 1(b)). Calu-3 (passage 35–37)
developed maximum TEER >400Ω·cm2 in all experiments,
reaching a peak between days 9 and 12. Thereafter, values4 Journal of Allergy
Table 3: A summary of outcomes for diﬀerent cell types. For β-Tubulin IV and MUC5AC, “localised” expression refers to expression in a
subset of cells. For E-Cadherin and ZO-1, expression was “localised” to the cell boundaries. ∗staining was similar to isotype control. HBEC
D1 is Donor 1 and HBEC D2 is Donor 2.
HBEC D1 HBEC D2 Calu-3 BEAS-2B BEAS-2B R1
TEER variable variable high low none
β-Tubulin IV mRNA low low high mid high
protein mid mid mid high mid
localised localised diﬀuse localised localised
MUC5AC mRNA high high high none none
protein high high high low none
localised localised localised diﬀuse
E-Cadherin mRNA high high mid mid none
protein high high high mid low
localised localised localised part localised diﬀuse
ZO-1 mRNA high high low mid mid
protein high high low mid∗ low∗
localised localised localised part localised diﬀuse
dropped slightly before reaching a more variable plateau
(Figure 1(c)). BEAS-2B reached a maximum TEER of 100–
150Ω·cm2 by around day 14 (Figure 1(d)), regardless of
passage,whilstBEAS-2BR1didnotdevelopsigniﬁcantTEER
(Figure 1(e)).
3.2. Primary Epithelial Cells and Cell Lines Show Morphologi-
cal Diﬀerences. The diﬀerent cells used in this study showed
diﬀerent phenotypes in culture. Phase contrast images give
a limited indication of these diﬀerences; however gross
morphologicaldiﬀerencesarepresent(Figure 2).Calu-3cells
took longest to become fully conﬂuent, probably due to
their tendency to form discrete colonies, unlike the other
cells which form a more even monolayer. HBECs showed
darker areas of denser (probably more stratiﬁed) cells and
lighter, less dense areas (Figures 2(a) and 2(b)). The Calu-
3c e l lp h e n o t y p ew a sm o r eh o m o g e n o u s( Figure 2(c)), with
increased mucus secretion apparent on washing. BEAS-2B
cells consistently developed an apical layer of material which
wasnotremovedbywashing(Figure 2(d)).BEAS-2BR1cells
had a very homogenous appearance, with no indication of
mucus production or diﬀerentiation (Figure 2(e)).
3.3. Primary Epithelial Cells and Cell Lines Express Charac-
teristic Diﬀerentiation Markers. At 28 days, cells were ﬁxed
and immunostained with antibodies speciﬁc for β-Tubulin
IVandMUC5AC (Figure 3,Table 3).Althoughβ-TubulinIV
is often expressed as a cytoskeletal protein, apical expression
is a commonly used marker of ciliated epithelial cells [27].
MUC5AC is expressed by goblet cells as a component of
mucus. Single image slices and z-stacks are shown to give an
indication of the overall level of expression and location in
the cell layer (basal versus apical). As ALI culture thickness
varied between cell types, the brightest image is shown in
each case. These were representative of 2-3 experiments per
donor or cell type. HBEC images shown for both donors are
from experiments reaching low TEER; however, β-Tubulin
IV and MUC5AC expression did not seem to reﬂect TEER
values (data not shown). HBECs presented apical β-Tubulin
IV expression in a subset of cells with a greater proportion
of cells from Donor 1 than Donor 2 showing expression.
β-Tubulin IV expression was observed in Calu-3 layers but
staining was only apparent below the apical pole of the cells.
Strong staining for β-Tubulin IV was obtained at the apical
side of BEAS-2B cells. BEAS-2B R1 showed apical staining in
a subset of cells. While both HBEC donors and Calu-3 cells
was stained positive for MUC5AC expression in a subset of
cells towards the apical side of the cell layer, neither BEAS-2B
subtypes showed signiﬁcant MUC5AC staining.
3.4. Primary Epithelial Cells and Cell Lines Express Tight Junc-
tion Proteins. Sections were costained for expression of ZO-
1 (a tight junction protein) and E-Cadherin (a cell adhesion
molecule and epithelial cell marker). Matched, single confo-
cal slices and z-stacks are shown. The brightest image from
each stack was chosen to allow comparison of maximum
expression in each cell culture system (Figure 4, Table 3).
Images are representative of 2-3 experiments per donor or
cell type. Both HBEC donors showed strong staining for ZO-
1 that was localised to cell membranes/cell-cell junctions.
This staining may be stronger in Donor 1 (where TEER
reached >350Ω·cm2) than Donor 2 (where low TEER
<150Ω·cm2 wasreached);however thediﬀerencein staining
was slight, compared to the variation in TEER. Overall,
ZO-1 staining was performed in ﬁve HBEC experiments
and no correlation between staining and ﬁnal TEER was
observed (data not shown). ZO-1 expression was weaker in
Calu-3 cells, despite their consistently high (>300Ω·cm2)
TEER, although similarly localised around cell boundaries.
In both BEAS-2B subtypes, ZO-1 expression was generally
diﬀuse; however, BEAS-2B cells showed membrane localised
expression in the apical cell layer. Both BEAS-2B subtypes
also showed high non-speciﬁc staining with the rabbitJournal of Allergy 5
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Figure 1: Development of transepithelial electrical resistance (TEER) in cells grown at (ALI). Diﬀerent primary cells and cell lines were
cultured at ALI over 21–28 days. TEER was measured every 2-3 days. Results from three separate experiments are shown for each cell
line/donor, six replicates per experiment. HBEC D1 is Donor 1 and HBEC D2 is Donor 2. Error bars show standard deviation.
isotype control, suggesting that ZO-1 protein levels may be
lowerthantheyappeared.E-Cadherinexpressionwasseenin
all cells except BEAS-2B R1. In both HBEC donors and Calu-
3, expression was tightly localised to the cell membrane/cell-
cell junctions, whilst in BEAS-2B expression was more dif-
fuse in the basal layer, but membrane was localised in the
apical layer.
3.5. Expression of Diﬀerentiation and Tight Junction Markers
Varies at the mRNA Level. Cells were harvested for RNA
at days 7, 14, and 21 during ALI diﬀerentiation and qPCR
performed for MUC5AC, β-Tubulin IV, E-Cadherin, and
ZO-1 (Figure 5, Table 3). Representative data from one of
two experiments are shown. HBEC results were taken from
experiments in which TEER reached >350Ω·cm2 (Donor 1)6 Journal of Allergy
(a) HBEC D1 (b) HBEC D2 (c) Calu-3
(d) BEAS-2B (e) BEAS-2B R1
Figure 2: Phase contrast images of cells at ALI. Diﬀerent primary cells and cell lines were cultured at ALI over 21–28 days. Phase contrast
images were taken at 21 days. Representative images are from three independent experiments.
and low TEER (Donor 2), whilst in replicate experiments,
TEER >350Ω·cm2 was reached in both donors. Expression
levels of all genes were signiﬁcantly diﬀerent between cell
types, although not between HBEC donors (P<0.001 for
all genes, 2-way ANOVA). These eﬀects were conserved in
a second independent experiment. Overall, no replicated
trends in gene expression over time were observed.
MUC5AC mRNA was similar in HBEC and Calu-3 cells.
Although expression of MUC5AC appears to increase at later
time points in the experiment shown (P<0.001, ANOVA),
this eﬀect was not conserved in a second independent exper-
iment. MUC5AC mRNA was not detected in the two BEAS-
2B subtypes (Figure 5(a)), consistent with immunoﬂuores-
cence results. β-Tubulin IV expression was highest in BEAS-
2B R1>Calu-3>BEAS-2B>HBEC (Figure 5(b)). This is in
contrast to the immunoﬂuorescence data where staining
was lowest in BEAS-2B R1. Expression of E-Cadherin was
highest in HBEC>Calu-3 and BEAS-2B>BEAS-2B R1 (not
detected) (Figure 5(c)), whereas immunoﬂuorescence was
similar in HBEC and Calu-3. ZO-1 expression (Figure 5(d))
was highest in HBEC>BEAS-2B and BEAS-2B R1>Calu-3.
4. Discussion
We have evaluated two primary human donors of bronchial
epithelial cells and Calu-3, BEAS-2B, and BEAS-2B R1 cell
culture systems as ALI models of the airway epithelium for
asthma research. For the ﬁrst time, cell lines were directly
compared to primary cells (Table 3). Using measurement
of TEER [8], immunoﬂuorescent staining, and qPCR, we
have investigated formation of tight junctions (ZO-1 and E-
Cadherin) as well as expression and localisation of suggested
markers of ciliated (β-Tubulin IV) and goblet (MUC5AC)
cells [27]. The main outcomes of our study are that
(1) primary HBECs demonstrate a variable diﬀerentiated
phenotype with the development of tight junctions and
TEERshowingexperiment,passage,anddonorvariation,(2)
Calu-3 cells exhibit many of the features of primary cells
but have distinct diﬀerences including, for example, ZO-
1 expression, and β-Tubulin IV localisation, although data
generated were more reproducible, and (3) as anticipated,
the BEAS-2B cell lines have limited diﬀerentiation capacity
in ALI models. These data have implications for the use of
both primary cells and cell lines for airway epithelial research
in asthma.
The use of primary HBECs in vitro has provided insight
into the potential mechanisms underlying asthma. This is
exempliﬁed by the recent ﬁndings of Xiao and colleagues
[13], demonstrating that asthmatic epithelial cells at ALI
show disrupted tight junctions and increased macromolec-
ular permeability, reﬂecting the ex vivo phenotype. Another
study by Hackett et al. observed an increased cytokineJournal of Allergy 7
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Figure 3: Immunoﬂuorescent confocal imaging of diﬀerentiation markers. Localisation patterns of β-Tubulin IV, MUC5AC, and the Mouse
IgG Isotype control at 28 days ALI were evaluated as described in the methods section. Single Z-slices are shown representing maximum
intensity observed, with the corresponding Z-stack image below for β-Tubulin IV and MUC5AC. Scale bar represents 50μm. Representative
images are from three independent experiments. HBEC images were taken from experiments with low TEER (Figure 1).
response to particulate matter, viral exposure, or mechanical
wounding[12],demonstratingthatasthmaticcellsmayshow
an aberrant inﬂammatory response to common environ-
mental stimuli. Primary and cell line systems also play a
role in dissecting the signalling networks involved in asthma.
Normal HBECs at ALI treated with TH2 cytokines, for
instance, show a potentially more secretory phenotype [15],
whilst in HBEC or BEAS-2B cells, leukotriene D4 signals
via EGFR to release IL-8 [17]. It is beyond doubt that
these epithelial ALI culture systems show utility in asthma
research; therefore in the current study, we aimed to provide
a direct comparison of a number of cell culture systems used
inasthmaresearchtohelpinselectionofappropriatesystems
for speciﬁc research questions.
WemeasuredexpressionofvariousproteinsatthemRNA
and protein levels as markers of diﬀerentiation. Although
β-Tubulin IV is widely expressed in cultured cells, apical
expression is often used to identify ciliated epithelial cells
at ALI [27, 30], whilst MUC5AC is a mucus protein,
expressed by goblet cells in the lung epithelium [31]. ZO-1
and E-Cadherin were included as markers of tight junction
formation and barrier integrity. An alternative method of
characterising ALI cultures is sectioning and performing
histochemical analysis to conﬁrm diﬀerentiation which gives
a clearer indication of the multilayer structure (e.g. [12]).
This study is limited by the use of immunoﬂuorescence only;
however we can obtain an overview of the phenotypes of
diﬀerent systems using this method.
In this study, we found that mRNA expression was
not tightly linked to immunostaining, particularly for β-
Tubulin IV, where HBECs showed very low mRNA levels
but high protein expression. This suggests that mRNA
expression may not be a good marker of functional status
for these genes. Diﬀerences between mRNA and protein
levels may reﬂect experimental or biological issues [32, 33].
In our study, samples were taken for qPCR at days 7–21
and for immunoﬂuorescence at day 28, a limitation which
may partially explain these diﬀerences. Some variation in
immunoﬂuorescence between samples may reﬂect diﬀerent
protein localisation; that is, diﬀuse faint staining may reﬂect
similar amounts of protein to bright, localised staining. At
the biological level, diﬀerences between mRNA and protein
may reﬂect variation in posttranscriptional mechanisms
between the cell types, such as mRNA stability or protein
synthesis and turn-over.
When culturing primary cells at ALI, the choice of med-
ium is very important, with diﬀerent media delivering dif-
ferent degrees of stratiﬁcation and cell phenotypes [5, 34].
Weuse“Gray’smedium”(BEDM),whichisreportedtoallow
development of a pseudostratiﬁed, polarised phenotype,8 Journal of Allergy
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Figure 4: Immunoﬂuorescent confocal imaging of tight junction proteins. Localisation patterns of ZO-1, E-Cadherin, and the Rabbit IgG
Isotype control at 28 days ALI were evaluated as described in the methods section. Images shown are single Z-stack slices representing
maximum intensity observed with the corresponding Z-stack image below and are of matched ﬁelds using dual staining. The corresponding
Mouse Isotype control for E-Cadherin can be seen in Figure 3. Scale bar represents 50μm. Representative images are from three independent
experiments. Images for HBEC Donor 1 were taken from an experiment reaching high TEER (>350Ω·cm2), whilst Donor 2 images were
taken from an experiment reaching low TEER (Figure 1).
including ciliated and goblet cells. This was conﬁrmed in our
hands, with localised expression of E-Cadherin, MUC5AC,
and β-Tubulin IV observed in both primary cell donors.
This model is reported to develop TEER [6, 7]. We found
that development of TEER was variable. TEER >350Ω·cm2
was obtained in the three experiments performed at passage
three, whilst TEER <150Ω·cm2 was obtained at passage
four, despite consistent expression of ZO-1 mRNA and
protein, localised to the cell membrane/cell-cell junctions.
These observations reinforce the assumption that localised
ZO-1 staining is not a surrogate marker for TEER and
vice versa, as well as the importance of passage when using
primary cells. The variation seen in this study between
diﬀerent experiments in a single donor is indicative of
the potential issues when comparing normal versus asthma
cells. Routinely, a single experiment is performed per
donor [12, 13]. It is important that these experiments are
performed with cells cultured for the same period of time
and in the same batch of medium to minimise experimental
variation.
The Calu-3 cell-line was established from a pleural eﬀu-
sion of a lung adenocarcinoma, derived from submucosal
gland serous cells [22–24]. Calu-3 cells are routinely cultured
in FCS-supplemented media [23] and spontaneously diﬀer-
entiate at ALI to give signiﬁcant TEER [23, 35]. These cells
are reported to express ZO-1 (a tight junction protein) and
E-Cadherin (an epithelial marker and cell adhesion protein).
We showed development of TEER >400Ω·cm2 and some
expression of ZO-1 and E-Cadherin. Interestingly, although
TEER was higher and more robust than in the primary
HBECs, ZO-1 expression at both the mRNA and protein
levels was lower, demonstrating that other tight junction
proteins have a role to play in maintaining TEER. The cells
expressed apical MUC5AC, as anticipated from their known
secretory phenotype. However, staining for β-Tubulin IV
expression was diﬀuse and not clearly located at the apical
side, suggesting that villi or cilia had not formed in the Calu-
3 model, in accordance with previous studies [23] that have
shown that ciliated cells are sparse in the Calu-3 cell line.
The BEAS-2B cell line was originally developed by imm-
ortalization of normal human bronchial epithelial cells using
AD12-SV40 virus [25]. This parental population of cells (as
well as subclone S6, not used here) retains the ability to
undergo squamous diﬀerentiation in response to TGFβ1o r
serum [29]. The BEAS-2B R1 line was derived from the
parental population by subculture in the presence of 5%Journal of Allergy 9
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(d) ZO-1
Figure 5: mRNA expression of diﬀerentiation and tight junction markers. Primary cells and cell lines were cultured at ALI over 21–28 days.
RNA was extracted at days 7, 14, and 21 during ALI diﬀerentiation for each cell line or donor. Expression of MUC5AC (a), β-Tubulin IV
(b), E-Cadherin (c), and ZO-1 (d) was measured. Data are normalised to the housekeeping gene HPRT1. Data are representative of two
independent experiments. Error bars show standard deviation. Yellow, red, and blue bars represent expression at days 7, 14, and 21 post-ALI,
respectively.
FCS. Unlike the parental cell line, these cells are induced to
proliferate by serum or TGFβ1 and have a more fusiform
appearance [29]. BEAS-2B cells (S6 subclone, similar to
the parental population) have previously been shown to
attain TEER >100Ω·cm2 at higher passage, in KGM (ker-
atinocyte growth medium, Clonetics) when supplemented
with calcium [26], or when grown in BEGM [36]o r
Laboratory of Human Carcinogenesis (LHC) serum-free
medium [37]. We used BEDM to drive BEAS-2B towards a
diﬀerentiated phenotype. These cells attained the reported
TEER of >100Ω·cm2. At ALI, these cells developed an apical
layer which stained strongly for β-Tubulin IV and showed
localised ZO-1 and E-Cadherin staining. However, staining
was fainter and more diﬀuse in the basal layer. It may be the
presence of this apical layer that increases the TEER, rather
than tight junction formation throughout the culture model.
These cells did not express MUC5AC.
There is no literature regarding the use of the BEAS-
2B R1 cell line at ALI; therefore these cells were included
essentially as a negative control, cultured in DMEM with
10% FCS. As anticipated, these cells did not develop TEER
and expressed minimal levels of E-Cadherin at the RNA and
protein level. The cells show apical β-Tubulin IV expression,
but no MUC5AC or localised ZO-1 expression. The reduced
E-Cadherin expression of this cell line suggests that they may
havedevelopedamoremesenchymalphenotypebyculturing
in the presence of FCS.
5. Conclusions
Normal and asthmatic primary bronchial epithelial cells and
cell lines are widely used in asthma research. ALI models are
usedtoattempttomorecloselyreplicatetheinvivosituation.10 Journal of Allergy
We have evaluated primary bronchial epithelial cells from
two donors and three cell lines in an ALI model with respect
to various markers of diﬀerentiation. Although primary cells
areregardedasthemostphysiologicallyrelevant,theyexhibit
a high degree of variability between donors, experiments,
and passage, particularly with respect to development of
TEER. Primary cells are costly and therefore unsuitable for
largescaleexperimentssuchasdrugscreening;theyalsohave
a ﬁnite lifespan and may be diﬃcult to manipulate. Cell lines
may, therefore, present an attractive alternative model. We
found that Calu-3 cells develop a high TEER and have a
patternofexpressionofepithelial markerssimilar toprimary
cells.Althoughfrequentlyusedinmonolayerculture,thetwo
BEAS-2B cell lines did not perform well in the ALI model,
showing poor TEER and lacking expression of epithelial
diﬀerentiation markers.
This work underlines the importance of using a well-
characterised model, suitably validated for the outcomes of
interest in any experiment. Importantly, this study highlights
some of the challenges ahead characterising primary human
airway epithelial cells from asthma and control donors
accountingfortheinter-andintradonorvariabilityidentiﬁed
in the current study.
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